Skip to main content

Table 1 Comparison of clinicopathological characteristics between adjuvant chemotherapy group and surgery-only group

From: Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?

 

Adjuvant chemotherapy (N = 150)

Surgery-only (N = 360)

P-value

 

N

%

N

%

 

Age (years)

  ≤ 65

108

72.0

246

69.3

0.461

  > 65

42

28.0

114

31.7

 

Gender

    

0.920

 Male

95

63.3

225

62.5

 

 Female

55

36.7

135

37.5

 

BMI (kg/m2)

    

0.990

  < 25

102

68.0

245

68.1

 

  ≥ 25

48

32.0

115

31.9

 

Type of resection

    

0.060

 STG

140

93.3

315

87.5

 

 TG

10

6.7

45

12.5

 

Reconstruction

    

0.168

 BI

70

46.7

174

48.3

 

 BII

68

45.3

139

38.6

 

 Roux-en-Y

12

8.0

47

13.1

 

Tumor location

    

0.416

 Upper

9

6.0

20

5.6

 

 Middle

44

29.3

128

35.6

 

 Lower

97

64.7

212

58.9

 

Gross type

    

0.812

 Elevated

30

20.0

77

21.4

 

 Non-elevated

120

80.0

283

78.6

 

Depth of invasion

    

0.420

 Mucosa

26

17.3

52

14.4

 

 Submucosa

124

82.7

308

85.6

 

No. of metastatic LN

    

0.015

 One

85

56.7

245

68.1

 

 Two

65

43.3

115

31.9

 

Lymphovascular invasion

    

<0.001

 Positive

91

60.7

150

41.7

 

 Negative

59

39.3

210

58.3

 

Histologic type

    

0.656

 Differentiated

23

12.5

161

87.5

 

 Undifferentiated

28

14.1

171

85.9

 
  1. BMI body mass index, LN lymph node, N number, STG subtotal gastrectomy, TG total gastrectomy
  2. P-value was italicized when less than 0.05